Journal article
Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective
Abstract
Ovarian cancer is leading cause of gynecologic cancer mortality in Canada. To date, overall survival (os) has been the most-used endpoint in oncology trials because of its relevance and objectivity. However, as a result of various factors, including the pattern of sequential salvage therapies, measurement of os and collection of os data are becoming particularly challenging. Phase ii and iii trials have therefore adopted progression-free …
Authors
Oza AM; Castonguay V; Tsoref D; Diaz–Padilla I; Karakasis K; Mackay H; Welch S; Weberpals J; Hoskins P; Plante M
Journal
Current Oncology, Vol. 18, No. 0, pp. 20–27
Publisher
MDPI
Publication Date
10 2011
DOI
10.3747/co.v18is2.939
ISSN
1198-0052